What’s On Our Minds What’s On Our Minds Brace yourself: U.S. Private Payer programs are rebooting for advanced cell and gene technologiesNovember 8, 2021 Three common mistakes development-stage life sciences companies makeSeptember 27, 2021 A new lens for investors: Three common clinical development pathway pitfallsAugust 29, 2021 Healthcare value is your key to success. Here’s how to get it right.July 26, 2021
